Berry Global, a designer, developer, and producer of patient-centred healthcare solutions, has launched the BerryHaler, a dual chamber, dry powder inhaler (DPI) with a dose counter designed to provide better patient access to and support the effective delivery of combination drugs.
Berry Global
BerryHaler
Marco Franza, sales and business development director for Berry Global Healthcare, said: “The BerryHaler demonstrates our commitment to delivering patient-centred products for our pharmaceutical customers with customisable, off-the-shelf solutions that help bring new treatments to market quickly. By partnering with our experts, customers can reduce investment costs and development time, relying on Berry for the device and focusing their resources on formulation development.”
The BerryHaler offers pharmaceutical companies a solution for the introduction of inhalation treatments that relieve the symptoms of Chronic Obstructive Pulmonary Disease (COPD), asthma, and other lung disorders. The design incorporates dual chamber Puck properties that enable the delivery of 30 doses of double and triple formulations simultaneously to the patient.
The all-plastic inhaler with no metal parts can be used for more complex inhalation treatments, including those that would otherwise require several different inhalers to achieve the correct dosage and combination drug treatments that cannot be combined in a single blend.
Special features include a bi-directional non-detachable mouthpiece cover, which can aid ease of use and help prevent cover loss, protecting the formulation and providing a more hygienic application for patients. The device also emits an audible signal when opening and closing the mouthpiece so that users know it has been fully opened for inhalation and then safely closed. The integrated dose counter helps patients to accurately monitor medication usage and remaining doses and avoid accidental over-or underdosage.
